Joint Formulary & PAD

Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Search

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A to Z of Drugs : B

Records returned : 143 (on 28 May 2025 at 05:00:12).

Show Icon and Status Keys

Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Red
Formulations :
  • Bladder instillation
Restrictions / Comments:

 
Links :
SPC
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important

On advice from palliative care specialist team

 
Links :
SPC
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Intrathecal injection
Restrictions / Comments:

Important
Severe chronic spasticity where oral drugs are intolerable or ineffective. Alternative to ablative neurosurgical procedures (specialist use only)
 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
NFD1
NICE
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
SPC
NHSE
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Severe disease only
 
Links :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE Specialist Centres only. Not a service that is provided by any of the Surrey Heartlands Acute Trusts.

 
Links :
SPC
NHSE
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
NHSE
R
Indication :
Status :
Green
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important
Preferred

Children only - ICS alone not recommended in adults with asthma.

First line ICS in children.

Prescribe by BRAND

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Not licensed in <18 years. ICS alone not recommended in adults with asthma.

Not to be initiated in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (breath actuated Metered Dose)
Restrictions / Comments:

Important

No dose counter, high carbon footprint.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (breath actuated Metered Dose)
Restrictions / Comments:

Important

No dose counter, high carbon footprint.

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Children only - ICS alone not recommended in adults with asthma.

Second line ICS in children (Clenil Modulite is 1st line).

No dose counter.

Prescribe by BRAND

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Nasal spray
Restrictions / Comments:

Important

Beclometasone 50mcg/dose (200 dose container) is recommended as a 1st line alternative treatment option. NOTE Beconase Hayfever and other container sizes (180 dose and 100 dose) are much more expensive and should not be used.

 
Links :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fostair NEXThaler 100/6

Prescribe by BRAND

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fostair NEXThaler 100/6 - licensed from 18 years of age.

Not licensed for AIR.

Second line in adult asthma requiring MART. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fostair NEXThaler 200/6 - High dose ICS/LABA for specialist recommendation only.

Not licensed for COPD.

Prescribe by BRAND.

 
Links :
Indication :
Status :
See narrative
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Fostair 100/6, 200/6 not licensed in under 18 years. Not licensed for AIR.

Not for initiation in new patients. Proxor device is much less expensive.

Further information is being sought with regard to Proxor / Fostair bioequivalence. To be reviewed in Jul/Aug 2025.

 
Links :
Status :
See narrative
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Fostair 100/6, 200/6 not licensed in under 18 years. Not licensed for AIR.

Not for initiation in new patients. Proxor device is much less expensive.

Further information is being sought with regard to Proxor / Fostair bioequivalence. To be reviewed in Jul/Aug 2025.

 
Links :
Status :
Green
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Proxor 100/6 - NEW device.

Fostair equivalent - Proxor is the most cost-effective ICS/formoterol pMDI. Licensed for MART in adults.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Proxor 100/6 (new device) - licensed for MART in adults - second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Not licensed in under 18 years.

Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Proxor 200/6 (new device) - higher dose ICS/LABA for specialist recommendation only.

Licensed for MART in adults - second line.

Not licensed in under 18 years. Not licensed for COPD

Proxor is equivalent to Fostair and is the most cost-effective ICS/formoterol pMDI.

 
Links :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Trimbow 87/5/9  (higher strengths not licensed for COPD)

Prescribe by BRAND

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Trimbow 87/5/9 and 172/5/9 - specialist recommendation only

 
Links :
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
NHSE
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Not assessed for formulary status. NICE terminated appraisal Jul 2022
 
Links :
SPC
NFD1
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
SPC
NHSE
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Only as add-on therapy for patients already on ezetimibe. Use the combination product (bempedoic acid with ezetimibe) in new patients. Specialist team initiation and supply of at least 3 months before transfer of prescribing to primary care.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Tablets
Restrictions / Comments:

Important
Indapamide is the preferred diuretic treatment option. No requirement to switch from bendroflumethiazide in stable patients.
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Service not currently provided by any Surrey Heartlands Trusts
 
Links :
SPC
NHSE
NICE
Status :
Green
Formulations :
  • Mouthwash
  • Oromucosal spray
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Injection
Restrictions / Comments:

Important
Contra-indicated in Penicillin Allergy. Follow local guidelines on the use of antimicrobials.
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
RSFT only - NHSE commissioned
 
Links :
SPC
NHSE
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Soluble tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Soluble tablets
Restrictions / Comments:

Important
Patients on everolimus treatment. Used as a mouthwash, in line with St Luke's SACT protocols
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Nasal drops
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Ear drops
Restrictions / Comments:

Important
0.1% eye / ear / nose drops
 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Eye drops
  • Eye ointment
Restrictions / Comments:

Important
Short-term use only. Primary Care prescribing on specialist recommendation
 
Links :
SPC
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Short-term use only. Primary Care prescribing on specialist recommendation.
 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Ear drops
Restrictions / Comments:

 
Links :
SPC
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
0.25% and 0.5% drops
 
Links :
Status :
Blue
Formulations :
  • Eye drops (preservative free)
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
0.25% preservative free drops
 
Links :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important

Off-label use.
Palliative care only - RSFT

 
Links :
SPC
Un
Indication :
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

Important
2nd line option where intravitreal dexamethasone is contraindicated
 
Links :
SPC
ICB
Un
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

 
Links :
SPC
ICB
Un
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

 
Links :
SPC
ICB
NICE
Indication :
Status :
Blue
Formulations :
  • Modified release tablets
  • Tablets
Restrictions / Comments:

Important
Primary care prescribing on recommendation from specialist team for Familial hypercholesterolaemia and hypertriglyceridaemia.
 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important
The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed with NICE recommendation not to use bezlotoxumab to prevent recurrence of C. Difficile infection because it is not cost effective. Bezlotoxumab will be given a NON-FORMULARY traffic light status for this indication.
 
Links :
SPC
NFD1
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

To be prescribed on recommendation from a specialist.

 
Links :
SPC
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Specialist centres only
 
Links :
SPC
NHSE
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
Note added January 2025 - this drug should be prescribed on recommendation from a specialist.
 
Links :
Status :
Blue
Formulations :
  • Eye drops
  • Eye drops (preservative free
  • unit dose)
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
SPC
ICB
NICE
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE Specialist Commissioned Services only. Not commissioned from any Surrey Heartlands Trusts.

 
Links :
SPC
NHSE
Indication :
Status :
Green
Formulations :
  • Cartridges
  • Pre-filled pen
Restrictions / Comments:

Important
Prescribe by brand and state form.
 
Links :
Indication :
Status :
Green
Formulations :
  • Cartridges
  • Pre-filled pen
  • Vials
Restrictions / Comments:

Important
Prescribe by brand and state form.
 
Links :
Indication :
Status :
Green
Formulations :
  • Cartridges
  • Pre-filled pen
  • Vials
Restrictions / Comments:

Important
Prescribe by brand and state form.
 
Links :
Indication :
Status :
Green
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Prescribe by brand and state form.
 
Links :
Indication :
Status :
Red
Formulations :
  • Gel
Restrictions / Comments:

Important
Specialist centres only
 
Links :
SPC
NHSE
Indication :
Status :
Green
Formulations :
  • Suppositories
  • Tablets
Restrictions / Comments:

Important
NOTE - 7.5mg suppositories are non-formulary. Only the licensed 5mg and 10mg suppositories should be prescribed
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important
7.5mg suppositories are unlicensed and not approved for use in Surrey Heartlands.
 
Links :
Indication :
Status :
Red
Formulations :
  • Gauze
  • Paste
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Gauze
  • Paste
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Un
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Preferred
 
Links :
Indication :
Status :
Green
Formulations :
  • Tablets
Restrictions / Comments:

Important
Preferred
Step 4 of the hypertension pathway. Bisoprolol / atenolol are the preferred, cardio-selective beta blockers for hypertension.
 
Links :
Status :
Red
Formulations :
  • Intravenous infusion
Restrictions / Comments:

 
Links :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important
Treatment of Liver haemangionas (chemotherapy competent consultant use)
 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Not Specified
Restrictions / Comments:

Important

NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.

 
Links :
SPC
NFD1
NHSE
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

RSFT: For chronic anal fissure. If first dose unsuccessful refer for sphincterectomy

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
  • RSFT: Neurology Only
  • SASH: Xeomin only
ADULTS. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

Includes blepharospasm and hemifacial spasm. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.

  • RSFT: Opthalmology and Neurology only. Dysport to be supplied to neurology if specifically requested
  • SASH: Xeomin only
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
  • RSFT: Cerebral palsy paediatrics only.
  • RSFT: Focal spasicitity:  neurology, joint paediatric and orthopaedic team or care of the elderly
  • SASH: Adults only

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

RSCH - endoscopy only.

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

 
Links :
SPC
Un
Status :
See narrative
Formulations :
  • Not Specified
Restrictions / Comments:

Important

Not assessed for formulary status. Contact pharmacy to make a formulary application.

 
Links :
SPC
NFD2
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

Important

For Chronic migraine only.

  • RSFT: Neurology only
  • SASH: Botox only Neurology Only
Neurology teams only. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC
 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

Focal dystonia, dystonic torticollis, cervical dystonia, spasmodic torticollis.

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

  • RSFT: Neurology only. Dysport to be supplied to neurology if specifically requested
 
Links :
SPC
Un
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

RSFT: Pain Team only

 
Links :
SPC
R
Un
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
  • RSFT: Urology Only
  • SASH: Botox only. Urology Only

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

 
Links :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC.

RSFT: Opthalmology Only

 
Links :
SPC
Un
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

RSCH - endoscopy only.

NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

 
Links :
SPC
Un
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important

RSFT - Dr Walker’s team use only; 50 units/vial. NOTE; different brands of botulinum toxin have difference licenses, please check SmPC

 
Links :
SPC
R
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
https://www.toxbase.org/
Stock not held by Surrey Trusts. Available from regional centres. Refer to TOXBASE / NPIS for advice
 
Links :
SPC
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Status :
Blue
Formulations :
  • Eye drops
Restrictions / Comments:

Important
Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care
 
Links :
Indication :
Status :
Blue
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

Important
Reserved for patients who remain uncontrolled or intolerant to all other adjuntive anti-epileptics. Only for use when levetiracetam has not been effective or tolerated.
To be initiated by a specialist.
 
Links :
SPC
R
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

Important
Reserved for patients who remain uncontrolled or intolerant to all other adjuntive anti-epileptics. Only for use when levetiracetam has not been effective or tolerated.
 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Not Specified
Restrictions / Comments:

 
Links :
SPC
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

 
Links :
SPC
ICB
NICE
Status :
Red
Formulations :
  • Intravitreal injection
Restrictions / Comments:

 
Links :
SPC
ICB
NICE
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
NFD1
Indication :
Status :
Blue
Formulations :
  • Tablets
Restrictions / Comments:

Important

Cabergoline should be considered 1st-line. Initiation and supply of at least one month of treatment before transfer of prescribing to primary care. Monitoring remains the responsibility of secondary care in line with position statement of the British Society of Echocardiography, the British Heart Valve Society and the Society for Endocrinology. https://pubmed.ncbi.nlm.nih.gov/30818417/

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Tablets
Restrictions / Comments:

Important
Not a 1st-line treatment option. On-going toxicity monitoring required
 
Links :
SPC
Status :
Non Formulary
Formulations :
  • Tablets
Restrictions / Comments:

 
Links :
SPC
NFD1
Indication :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Not for initiation in new patients.

 
Links :
Indication :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Children only - ICS alone not recommended in adults with asthma.

DPI licensed in children, cost effective.

Prescribe by BRAND.

Licensed in children.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Children only - ICS alone not recommended in adults with asthma.

Licensed in children. Second line (Easyhaler budesonide device is preferred).

Prescribe by BRAND

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Nasal spray
Restrictions / Comments:

Important

Mometasone Furoate 50mcg/dose 140 dose container is the recommended 1st line treatment option. Budesonide is recommended as a 2nd line option

 
Links :
Status :
Red
Formulations :
  • Nebules
Restrictions / Comments:

Important
Off-label use
 
Links :
SPC
Un
Status :
Green
Formulations :
  • Foam enema
Restrictions / Comments:

Important
Steroid safety considerations
 
Links :
Status :
Red
Formulations :
  • Modified release capsules
Restrictions / Comments:

Important
Steroid safety considerations
3mg MR capsules - gastroenterology team only
 
Links :
Status :
See narrative
Formulations :
  • Suppositories
Restrictions / Comments:

Important
Steroid safety considerations

Not assessed for formulary status. Applications for formulary entry via APC.

 
Links :
Indication :
Status :
Green
Formulations :
  • Nasal spray
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Modified release capsules
Restrictions / Comments:

Important
Not interchangeable with other budesonide preparations
 
Links :
SPC
ICB
NICE
Status :
Red
Formulations :
  • Oro-dispersible
Restrictions / Comments:

 
Links :
SPC
Status :
Blue
Formulations :
  • Oro-dispersible
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist recommendation following patient initiation and education on nebuliser therapy.

 
Links :
Status :
Blue
Formulations :
  • Nebules
Restrictions / Comments:

Important

Specialist recommendation following patient initiation and education on nebuliser therapy.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

DuoResp Spiromax 160/4.5 - licensed for AIR and MART from 12 years of age.

Second line. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

DuoResp Spiromax 320/9 - higher dose ICS/LABA for specialist recommendation only.

Prescribe by BRAND.

 
Links :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

DuoResp Spiromax 160/4.5 - second line (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI).

Prescribe by BRAND.

 
Links :
Status :
Non Formulary
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

DuoResp Spiromax 320/9 - this strength is not recommended in the Surrey Heartlands COPD guidelines.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fobumix Easyhaler 80/4.5 and 160/4.5 - licensed in children.

Cost-effective choice for AIR and MART.

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Fobumix Easyhaler 320/9 - higher dose ICS/LABA for specialist recommendation only.

Prescribe by BRAND.

 
Links :
Status :
Green
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Prescribe by BRAND.

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Symbicort 100/3 - Useful in children and under 18yrs . Useful for patients needing a pMDI licensed for MART.

Prescribe by BRAND

 
Links :
Status :
Green (see narrative)
Formulations :
  • Inhaler (Metered Dose)
Restrictions / Comments:

Important

Symbicort 200/6 - only for use if an MDI is needed.

 
Links :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Symbicort Turbohaler 400/12 - second line (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Prescribe by BRAND

 
Links :
Indication :
Status :
Green (see narrative)
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Symbicort Turbohaler 100/6 and 200/6 - Licensed for AIR and MART.

More costly device so second line option. (Fobumix Easyhaler (budesonide/formoterol) is the more cost-effective option DPI)

Prescribe by BRAND.

 
Links :
Indication :
Status :
Blue
Formulations :
  • Inhaler (dry powder)
Restrictions / Comments:

Important

Symbicort Turbohaler 400/12 - higher dose ICS/LABA for specialist recommendation only.

Prescribe by BRAND

 
Links :
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
NHSE
NICE
Indication :
Status :
Green
Formulations :
  • Oral solution
  • Tablets
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Red
Formulations :
  • Injection
Restrictions / Comments:

 
Links :
SPC
Indication :
Status :
Green (see narrative)
Formulations :
  • Patches
Restrictions / Comments:

Important
Prescribe by brand. Care: available as 3-day, 4-day and 7-day patches. Refer to Trust / Primary Care Pharmacy advice for locally preferred brands
 
Links :
Indication :
Status :
Blue
Formulations :
  • Sublingual tablets
Restrictions / Comments:

Important
Use in patients unable to tolerate oral medications or where morphine is contra-indicated. If this formulation is indicated, prescribing may be initiated and stabilised by a specialist service but has the potential to transfer to primary care WITHOUT a formal shared care agreement. In some circumstances a specialist may recommend that prescribing can be started in primary care
 
Links :
Indication :
Status :
Non Formulary
Formulations :
  • Nasal spray
  • Subcutaneous injection (sc)
Restrictions / Comments:

 
Links :
SPC
NFD1